about
Decline in prefrontal catecholamine synthesis explains age-related changes in cognitive speed beyond regional grey matter atrophyVentral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligenceIgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment.Accurate determination of metabolic rates from dynamic positron emission tomography data with very-low temporal resolution.Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls.Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression.Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET.Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLCVentral striatal dopamine reflects behavioral and neural signatures of model-based control during sequential decision making.CT-based attenuation correction in I-123-ioflupane SPECTCerebral glucose utilisation in hepatitis C virus infection-associated encephalopathyChronic alcohol intake abolishes the relationship between dopamine synthesis capacity and learning signals in the ventral striatum.Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.A hidden giant: Wallenberg syndrome and aortal wall thickening as an atypical presentation of a giant cell arteritis.Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkersBrain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma.Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.MR Imaging of Prostate Cancer: Diffusion Weighted Imaging and (3D) Hydrogen 1 (H) MR Spectroscopy in Comparison with Histology.Molecular Imaging of Abdominal Aortic Aneurysms.Motor plasticity after extra-intracranial bypass surgery in occlusive cerebrovascular disease.Aberrant Salience Is Related to Reduced Reinforcement Learning Signals and Elevated Dopamine Synthesis Capacity in Healthy Adults.Interactions between glutamate, dopamine, and the neuronal signature of response inhibition in the human striatum.Ventilation/perfusion SPECT/CT in patients with pulmonary emphysema. Evaluation of software-based analysing.Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons.Complete remission of critical neurohistiocytosis by vemurafenib.Awakening with amantadine from a persistent vegetative state after subarachnoid haemorrhage.Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET.IBZM SPECT and FDG PET in the differential diagnosis of Parkinsonian syndromes: comparison with respect to inter-rater agreement.Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT.18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.[FDG PET for the localization diagnosis in inflammatory disease of unknown origin--two case reports]Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque.Hydrocephalus-induced neuroleptic malignant-like syndrome with reduced dopamine transporters.Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction.Fully automatic detection of deep white matter T1 hypointense lesions in multiple sclerosis.[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients.A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.
P50
Q28531473-C0F79AE2-0037-45D9-AB93-CFEEB6E911F5Q28531475-043738AC-2667-40F6-9C36-8E3888CB34EFQ30454306-C22E700C-2CB3-4321-9929-7923B26B6A87Q30814688-9D0C2EF5-3EBF-43A8-9B0C-5361ABB7D38DQ33539021-3E39FFEE-9222-4EDD-8F3F-D4CE5C3F15ABQ33907766-A7F93E8D-7F58-4006-A795-3724502B254EQ34531862-75D5A6D7-96CD-4F42-A281-CE5BE2780138Q34695293-B21818B8-2FBA-45DF-B977-CF6336D3F103Q35062858-EC1D7B49-E80E-42F0-8EF5-7FAC2FA0FF05Q35287222-B34D890E-4CE4-4604-8527-DB3EE29401C6Q35534180-509754B9-887A-4DF4-B007-A28A6E56A7E0Q35683932-E0C6832F-ABE8-4F18-A1B7-0403C47B4684Q35925439-6C14FFA6-7597-4224-B5EF-943E30440242Q36745871-511A3373-B2DA-4461-BC34-035C6A38BA4BQ36929004-568599CD-769D-463C-9340-0BBBCD7E53D6Q36951072-7A9168E0-C881-4BEE-9C7C-4CF971C69C93Q38712774-6AD765EB-178E-4605-A560-C487865D503AQ38782559-4636EA35-CAAA-4B96-82E6-56FFF9EDFEDAQ39097965-07DF01D9-F728-49BB-9036-1B91E0A9387CQ39696422-1084B851-53B8-4BD7-BC37-FE684347D08BQ40730801-F2E6F862-4733-4C76-82FB-1C51832CD4FDQ40733200-7BBE2282-1557-4EE0-9AFC-0AEDE0BBB949Q41434448-C3767F72-2CF6-4DBE-AEA7-B7212F4E3083Q42096185-FCF5D448-30CC-4A92-8387-58C8F7E9C423Q42142748-C61020E5-D351-40A1-9859-9B3B37C4A332Q42364209-CFD93089-88F7-4B75-9A8F-9F5D241B8145Q42858769-63F7924A-83E2-4043-B4A7-1E45AD4ADF23Q43054189-FE35C050-46DE-4FA3-A01C-77A1F6BF71E2Q43122494-218E6DE5-8FB3-43F7-93A4-5EA40529878FQ43542634-AB3658C9-C140-41F8-BC6E-0DB45DAB409FQ43688018-B3B9022D-440F-42BE-AFE0-79363B0930D2Q43736795-2827F327-02E3-45B5-8878-42AE45473B0CQ43985646-873E63AE-DD6B-4BF6-BB40-12FC60F3DAF2Q44086414-D56371FE-14AE-4156-973B-E82DE015F4FCQ44233511-D477E2E6-32D9-437E-B1FA-0E7523971FDFQ44302225-1DE14B64-AA10-4A58-8CAD-9D1420C8BEC3Q44423731-EEE042B3-CF71-4124-9347-F9574F5C5021Q44863968-A5FC900D-D3E9-42E6-BBA6-76B90B69374CQ44960106-D64E1541-06E0-4914-983F-1C47BAF8D3E7Q45053729-050DCFD2-F5E6-4D84-9988-D763C2C3C2A0
P50
description
researcher
@en
name
Buchert R
@nl
Ralph Buchert
@en
type
label
Buchert R
@nl
Ralph Buchert
@en
altLabel
Buchert R
@en
prefLabel
Buchert R
@nl
Ralph Buchert
@en
P106
P31
P496
0000-0002-0945-0724